FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes

(MedPage Today) — The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and children with diabetes, the agency announced Friday.
Like its reference counterpart, insulin aspart (Novolog…

Source link : https://www.medpagetoday.com/endocrinology/type1diabetes/114245

Author :

Publish date : 2025-02-14 22:20:44

Copyright for syndicated content belongs to the linked Source.